jueves, 2 de julio de 2020

BMC Cancer | Articles

BMC Cancer | Articles



  1. Cost-effectiveness is a pivotal consideration for clinical decision making of high-tech cancer treatment in developing countries. Intensity-modulated proton radiation therapy (IMPT, the advanced form of proton...
    Authors:Guo Li, Bo Qiu, Yi-Xiang Huang, Jerome Doyen, Pierre-Yves Bondiau, Karen Benezery, Yun-Fei Xia and Chao-Nan Qian
    Citation:BMC Cancer 2020 20:599
    Content type:Research article
     
    Published on: 
  2. Lymph node metastasis is more likely in early-stage breast cancer with lower tumor-infiltrating lymphocyte (TIL) density. Therefore, we investigated the correlation between TILs and lymph node metastasis in cT...
    Authors:Koji Takada, Shinichiro Kashiwagi, Yuka Asano, Wataru Goto, Rika Kouhashi, Akimichi Yabumoto, Tamami Morisaki, Masatsune Shibutani, Tsutomu Takashima, Hisakazu Fujita, Kosei Hirakawa and Masaichi Ohira
    Citation:BMC Cancer 2020 20:598
    Content type:Research article
     
    Published on: 
  3. A major cause of disease-related death in nasopharyngeal carcinoma (NPC) is the development of distant metastasis (DM) despite combination chemoradiotherapy treatment. We previously identified and validated a ...
    Authors:Pierre-Antoine Bissey, Mona Teng, Jacqueline H. Law, Wei Shi, Jeff P. Bruce, Valentin Petit, Sai W. Tsao, Kenneth W. Yip and Fei-Fei Liu
    Citation:BMC Cancer 2020 20:597
    Content type:Research article
     
    Published on: 
  4. Soft-tissue metastasis (STM) is a relatively rare, but not exceptional, manifestation of lung cancer. The purpose of this study was to evaluate the imaging features of STM from lung cancer using fluorine-18 fl...
    Authors:Tingting Xu, Xinyi Zhang, Shumao Zhang, Chunfeng Liu, Wenhui Fu, Chengrun Zeng and Yue Chen
    Citation:BMC Cancer 2020 20:596
    Content type:Research article
     
    Published on: 
  5. Unlike other breast cancer subtypes that may be treated with a variety of hormonal or targeted therapies, there is a need to identify new, effective targets for triple-negative breast cancer (TNBC). It has rec...
    Authors:Gina Sizemore, Sarah McLaughlin, Mackenzie Newman, Kathleen Brundage, Amanda Ammer, Karen Martin, Elena Pugacheva, James Coad, Malcolm D. Mattes and Han-Gang Yu
    Citation:BMC Cancer 2020 20:595
    Content type:Research article
     
    Published on: 
  6. Patients with cancer have an increased risk of malnutrition which is associated with poor outcome. The Mini Nutritional Assessment (MNA®) is often used in older patients with cancer but its relation to outcome...
    Authors:G. Torbahn, T. Strauss, C. C. Sieber, E. Kiesswetter and D. Volkert
    Citation:BMC Cancer 2020 20:594
    Content type:Research article
     
    Published on: 
  7. An amendment to this paper has been published and can be accessed via the original article.
    Authors:Qi Wang, Zixiang Wu, Tianwei Zhan, Shuai Fang, Sai Zhang, Gang Shen and Ming Wu
    Citation:BMC Cancer 2020 20:593
    Content type:Correction
     
    Published on: 
    The original article was published in BMC Cancer 2019 19:500
  8. Metastatic colorectal cancer (CRC) continues to be a major health problem, and current treatments are primarily for disease control and palliation of symptoms. In this study, we developed a precision medicine ...
    Authors:Erdem Altunel, Roham S. Roghani, Kai-Yuan Chen, So Young Kim, Shannon McCall, Kathryn E. Ware, Xiling Shen, Jason A. Somarelli and David S. Hsu
    Citation:BMC Cancer 2020 20:592
    Content type:Research article
     
    Published on: 
  9. The prognosis of patients with progressive or recurrent high-grade gliomas (HGGs) after surgery remains poor. Iodine-125 brachytherapy is emerging as a salvage method for the treatment of gliomas. This study a...
    Authors:Congxiao Wang, Shifeng Liu, Lijing Peng, Kaixian Zhang, Wei Li, Hao Zhang, Ying Luan, Peishun Li and Xiaokun Hu
    Citation:BMC Cancer 2020 20:591
    Content type:Research article
     
    Published on: 
  10. Ex vivo drug screening refers to the out-of-body assessment of drug efficacy in patient derived vital tumor cells. The purpose of these methods is to enable functional testing of patient specific efficacy of a...
    Authors:Rami Mäkelä, Antti Arjonen, Ville Härmä, Nina Rintanen, Lauri Paasonen, Tobias Paprotka, Kerstin Rönsch, Teijo Kuopio, Juha Kononen and Juha K. Rantala
    Citation:BMC Cancer 2020 20:590
    Content type:Research article
     
    Published on: 
  11. We examined the association between obesity and prostate cancer based on both body mass index (BMI) and waist circumference (WC) using the National Health Insurance System (NHIS) database for the entire male p...
    Authors:Jin Bong Choi, Jun-Pyo Myong, Yunhee Lee, Inah Kim, Jung Ho Kim, Sung-Hoo Hong and U-Syn Ha
    Citation:BMC Cancer 2020 20:589
    Content type:Research article
     
    Published on: 
  12. Prostate Cancer (PCa) is the second most common cancer in men where advancements have been made for early detection using imaging techniques, however these are limited by lesion size. Immune surveillance has e...
    Authors:Ali Mehdi, David Cheishvili, Ani Arakelian, Tarek A. Bismar, Moshe Szyf and Shafaat A. Rabbani
    Citation:BMC Cancer 2020 20:588
    Content type:Research article
     
    Published on: 
  13. Gastric cancer is one of the deadliest cancer entities worldwide. While surgery is the only curative treatment option in early tumors, for locally advanced and metastatic patients further therapeutic targets a...
    Authors:Jan Rehkaemper, Michael Korenkov, Alexander Quaas, Josef Rueschoff, Aylin Pamuk, Thomas Zander, Axel M. Hillmer, Reinhard Buettner, Arnulf Heinrich Hoelscher, Christiane Josephine Bruns, Heike Loeser, Hakan Alakus and Birgid Schoemig-Markiefka
    Citation:BMC Cancer 2020 20:587
    Content type:Research article
     
    Published on: 
  14. HOXA family genes were crucial transcription factors involving cell proliferation and apoptosis. While few studies have focused on HOXA10 in AML. We aimed to investigate the prognostic significance of HOXA10.
    Authors:Chao Guo, Qian-qian Ju, Chun-xia Zhang, Ming Gong, Zhen-ling Li and Ya-yue Gao
    Citation:BMC Cancer 2020 20:586
    Content type:Research article
     
    Published on: 
  15. Previous studies have shown that branched-chain amino acid transferase 1 (BCAT1) is associated with tumour progression in triple-negative breast cancer (TNBC). Furthermore, CD133 has emerged as a novel cancer ...
    Authors:Yu Song, Bin Zhao, Yali Xu, Xinyu Ren, Yan Lin, Liangrui Zhou and Qiang Sun
    Citation:BMC Cancer 2020 20:584
    Content type:Research article
     
    Published on: 
  16. P53 pathway inactivation plays an important role in the process of breast cancer tumorigenesis. Post-translational protein modification abnormalities have been confirmed to be an important mechanism underlying...
    Authors:Qian Pu, Yan-rong Lv, Ke Dong, Wen-wen Geng and Hai-dong Gao
    Citation:BMC Cancer 2020 20:583
    Content type:Research article
     
    Published on: 
  17. As a natural alkaloid product isolated from Sophora alopecuroides. L, Sophoridine reshapes gastric cancer immune microenvironment via inhibiting chemotaxis and M2 polarization of tumor-associated macrophages (TAM...
    Authors:Zhiyang Peng, Qing Guan, Jianfei Luo, Wenhong Deng, Jiasheng Liu, Ruicheng Yan and Weixing Wang
    Citation:BMC Cancer 2020 20:582
    Content type:Research article
     
    Published on: 
  18. Esophageal carcinoma (EC) is the seventh-most prevalent tumor in the world, which is still one of the primary causes of tumor-related death. Identifying noteworthy biomarkers for EC is particularly significant...
    Authors:Yiding Li, Guiling Wu, Wanli Yang, Xiaoqian Wang, Lili Duan, Liaoran Niu, Yujie Zhang, Jinqiang Liu, Liu Hong and Daiming Fan
    Citation:BMC Cancer 2020 20:581
    Content type:Research article
     
    Published on: 
  19. Non-small cell lung cancer (NSCLC) remains a huge health burden for human health and life worldwide. Our study here was to illuminate the relevance of microRNA-130a-5p (miR-130a-5p) on growth and epithelial me...
    Authors:Fang Ma, Yangchun Xie, Yiyu Lei, Zengshuyu Kuang and Xianling Liu
    Citation:BMC Cancer 2020 20:580
    Content type:Research article
     
    Published on: 
  20. To explore the diagnostic value of radiomics features of preoperative computed tomography (CT) for triple negative breast cancer (TNBC) for better treatment of patients with breast cancer.
    Authors:Qingliang Feng, Qiang Hu, Yan Liu, Tao Yang and Ziyi Yin
    Citation:BMC Cancer 2020 20:579
    Content type:Research article
     
    Published on: 
  21. This pilot trial aimed to investigate whether modified short-term fasting (mSTF) reduces the incidence of chemotherapy-induced toxicities and whether an initial ketogenic diet (KD) as fasting supportive diet r...
    Authors:Stefanie Zorn, Janine Ehret, Rebecca Schäuble, Beate Rautenberg, Gabriele Ihorst, Hartmut Bertz, Paul Urbain and Anna Raynor
    Citation:BMC Cancer 2020 20:578
    Content type:Research article
     
    Published on: 
  22. Qualitative research on cancer patients’ survivor-identity and lived experiences in low- and middle-income countries is scarce. Our study aimed at exploring the concept and experience of survivorship for Mexic...
    Authors:Felicia Marie Knaul, Svetlana V. Doubova, María Cecilia Gonzalez Robledo, Alessandra Durstine, Gabriela Sophia Pages, Felicia Casanova and Hector Arreola-Ornelas
    Citation:BMC Cancer 2020 20:577
    Content type:Research article
     
    Published on: 
  23. Omega-3 polyunsaturated fatty acids (PUFAs) were proposed to have potential effects against inflammation and cancer. However, results from epidemiology studies remain inconsistent. We aimed to explore the asso...
    Authors:Peiqin Li, Boer Shan, Keyu Jia, Fan Hu, Ying Xiao, Jusheng Zheng, Yu-Tang Gao, Huaying Wang and Ying Gao
    Citation:BMC Cancer 2020 20:576
    Content type:Research article
     
    Published on: 
  24. In patients undergoing major liver resection, portal vein embolization (PVE) has been widely used to induce hypertrophy of the non-embolized liver in order to prevent post-hepatectomy liver failure. PVE is a s...
    Authors:Emmanuel Deshayes, Lauranne Piron, Antoine Bouvier, Bruno Lapuyade, Emilie Lermite, Laurent Vervueren, Christophe Laurent, Jean-Baptiste Pinaquy, Patrick Chevallier, Anthony Dohan, Agnès Rode, Christian Sengel, Chloé Guillot, François Quenet and Boris Guiu
    Citation:BMC Cancer 2020 20:574
    Content type:Study protocol
     
    Published on: 
  25. This study aims to determine the real incidence of pericolic lymph nodes metastasis beyond 10 cm proximal to the tumor (pPCN) and its prognostic significance in rectal cancer patients.
    Authors:Xuyang Yang, Erliang Zheng, Lina Ye, Chaoyang Gu, Tao Hu, Dan Jiang, Du He, Bing Wu, Qinbing Wu, Tinghan Yang, Mingtian Wei, Wenjian Meng, Xiangbing Deng, Ziqiang Wang and Zongguang Zhou
    Citation:BMC Cancer 2020 20:573
    Content type:Research article
     
    Published on: 
  26. KRAS mutations are prevalent in 40–45% of patients with colorectal cancer (CRC) and targeting this gene has remained elusive. Viruses are well known immune sensitizing agents. The therapeutic efficacy of oncolyti...
    Authors:Ruwan Parakrama, Elisha Fogel, Carol Chandy, Titto Augustine, Matt Coffey, Lydia Tesfa, Sanjay Goel and Radhashree Maitra
    Citation:BMC Cancer 2020 20:569
    Content type:Research article
     
    Published on: 

No hay comentarios:

Publicar un comentario